2020
DOI: 10.36660/ijcs.20190157 View full text |Buy / Rent full text
|
|

Abstract: Background: The prevention of cardiovascular disease (CVD) is important in clinical practice due to its high morbidity and mortality. Different guidelines have recommended the use of different cardiovascular risk assessment tools, which may have implications on therapeutic decisions. Objective: To evaluate the agreement rate between the Framingham risk score (FRS) and the Systematic Coronary Risk Evaluation (SCORE) tool on CVD risk assessment in disease-free subjects. Methods: Cross-sectional study with a samp… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
4
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

0
4
0
Order By: Relevance
“…Patients with diabetes are at high cardiovascular risk regardless of the score used. 4 In the study by Marasciulo et al 5 people with diabetes represented 27.5% of the sample. The Framingham score classified 71.4% of these patients as high-risk.…”
mentioning
“…In order to extend the risk prediction, some models are able to estimate 30-year or lifelong risks, but they require validations in different populations. 3 Marasciulo et al 5 compared the use of SCORE with the Framingham risk score in a Brazilian population. 5 The SCORE tool used data from more than 250 000 individuals in 12 European countries to predict cardiovascular death in 10 years, with different models for countries with high or low incidence of cardiovascular disease (SCORE-High and SCORE-Low, respectively).…”
mentioning
See 2 more Smart Citations